BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22516803)

  • 1. Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time.
    Harmer CJ; Triccas JA; Hu H; Rose B; Bye P; Elkins M; Manos J
    Microb Pathog; 2012 Jul; 53(1):37-43. PubMed ID: 22516803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection.
    Hawdon NA; Aval PS; Barnes RJ; Gravelle SK; Rosengren J; Khan S; Ciofu O; Johansen HK; Høiby N; Ulanova M
    FEMS Immunol Med Microbiol; 2010 Jul; 59(2):207-20. PubMed ID: 20528926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
    Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
    Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
    Anuj SN; Whiley DM; Kidd TJ; Ramsay KA; Bell SC; Syrmis MW; Grimwood K; Wainwright CE; Nissen MD; Sloots TP
    Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates.
    Tramper-Stranders GA; van der Ent CK; Molin S; Yang L; Hansen SK; Rau MH; Ciofu O; Johansen HK; Wolfs TF
    Clin Microbiol Infect; 2012 Jun; 18(6):567-74. PubMed ID: 21883670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
    Tingpej P; Smith L; Rose B; Zhu H; Conibear T; Al Nassafi K; Manos J; Elkins M; Bye P; Willcox M; Bell S; Wainwright C; Harbour C
    J Clin Microbiol; 2007 Jun; 45(6):1697-704. PubMed ID: 17392437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
    Stepińska M; Trafny EA
    Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
    Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital.
    Bradbury RS; Champion AC; Reid DW
    J Hosp Infect; 2009 Oct; 73(2):151-6. PubMed ID: 19699556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum.
    Bradbury RS; Reid DW; Inglis TJ; Champion AC
    Microbiol Immunol; 2011 Apr; 55(4):224-30. PubMed ID: 21272061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease.
    Martínez-Solano L; Macia MD; Fajardo A; Oliver A; Martinez JL
    Clin Infect Dis; 2008 Dec; 47(12):1526-33. PubMed ID: 18990062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic.
    Griffiths AL; Wurzel DF; Robinson PJ; Carzino R; Massie J
    J Cyst Fibros; 2012 Jan; 11(1):49-52. PubMed ID: 21907639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.